Loading organizations...
Key people at Peppermint Venture Partners.
Peppermint Venture Partners was founded in 2000 by Joachim Rautter (Co-Founder and Managing Director) and Klaus Stoeckemann (Managing Director & Co-Founder).
Peppermint Venture Partners (PVP) is a Berlin-based private venture capital firm. It focuses on investing in early-stage biotech and healthcare companies across Europe, targeting disruptive innovations in medical devices, pharmaceuticals, and broader healthcare. PVP aims to foster transformative solutions by supporting novel technologies that advance patient care and improve clinical outcomes through strategic investment.
Peppermint Venture Partners was established in 2008 by co-founders Ingeborg Neumann, Dr. Joachim Rautter, and Dr. Klaus Stöckemann. The team identified a clear demand for specialized early-stage capital and strategic guidance within the evolving European healthcare and life sciences landscape, forming a dedicated investment vehicle to propel promising scientific ventures toward commercial success.
The firm serves innovative European biotech and healthcare startups, providing essential early-stage funding and strategic support. Peppermint Venture Partners' vision is to advance healthcare by backing entrepreneurial teams developing solutions that address critical medical needs and improve patient outcomes, thus redefining future medical care. The firm actively seeks pioneering companies with this potential.
Peppermint Venture Partners was founded in 2000 by Joachim Rautter (Co-Founder and Managing Director) and Klaus Stoeckemann (Managing Director & Co-Founder).
Key people at Peppermint Venture Partners.
Peppermint Venture Partners has 6 tracked investments across 5 companies. The latest tracked deal is $5.8M Series B in CryoTherapeutics in July 2016.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jul 7, 2016 | CryoTherapeutics | $5.8M Series B | — | Getz Brothers, High Tech Grunderfonds, KFW, NRW.BANK |
| Jan 5, 2016 | Emperra | $3.1M Series B | — | Investitionsbank DES Landes Brandenburg, Robert Bosch Venture Capital |
| Jul 30, 2015 | CEVEC Pharmaceuticals | $4.9M Other Equity | — | Frank Ubags, Nicole Faust, G.A.T. Holding, Investtodate, KFW, NRW.BANK |
| Nov 11, 2014 | Humedics GmbH | $7.8M Series C | Robert Schier, Christian Schneider | High Tech Grunderfonds, IBB Ventures, KFW, Ventegis Capital |
| Mar 21, 2013 | CryoTherapeutics | $3.9M Series A | — | — |
| Aug 30, 2012 | Implandata Ophthalmic Products | $2.0M Series A Extension | Enjoyventure, Peppermint Venture Partners | KFW |
